Adiponectin

Sample type: -

Serum or plasma (EDTA)

Uses: -

• Higher adiponectin levels are associated with a lower risk of type 2 diabetes across diverse populations, consistent with a dose–response relationship.

• Levels of adiponectin are significantly reduced in obese subjects compared to nonobese subjects. Levels of adiponectin are reduced in diabetics compared to nondiabetics. Weight reduction significantly increases circulating levels.

Precaution: -

No special precaution required.

Interfere action: -

• Adiponectin exerts some of its weight reduction effects via the brain. This is like the action of leptin, but the two hormones perform complementary actions and can have additive effects.

• Due to its important cardiometabolic actions, adiponectin represents a biologic molecule worth being studied as a new emerging biomarker of disease and as a target for pharmacologic treatments.

Pre analytical error: -

• The patient eating much sugar before test.

• Use another test tube.

Corrective action: -

• The lab specialist should be telling the patient the procedure before testing.

• We must use the red-top tube, gel-barrier tube, or lavender-top (EDTA) tube.

Post analytical error: -

• Unlabeled the test.

• Send the result to wrong patient.

• Wrong calculations.

Corrective action: -

• Ask for another sample and apologize for the mistake.

• Repeat the calculation and ask to resend the result and apologize.

Reference range: -